Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Inflammation × Ashwagandha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Inflammation 1 Autoimmune Diseases 1

Interventions

palbociclib 2 salicylsalicylic acid 1 Sevoflurane 1 Rivaroxaban 1 Propofol 1 Bevacizumab 1 Ashwagandha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

National University of Natural Medicine

Phase 1 Completed

Autoimmune Diseases, Inflammation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡